Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Boehringer collaborates with biotech firm to detect global disease outbreaks
Lifebit's REAL platform will monitor and interpret scientific publications and other open sources to identify infectious disease outbreaks.

Project will combine real-world evidence with AI to track transboundary infections.

Boehringer Ingelheim has announced a multi-year partnership with biotech firm Lifebit to detect and report global disease outbreaks. 

Through the partnership, scientists will work collaboratively to combine real-world evidence and the latest AI algorithms to identify diseases, particularly those that cross borders, and respond accordingly. 

Lifebit's REAL platform analyses data harvested from millions of tweets, news articles and scientific publications to notify users of relevant disease outbreaks, such as COVID-19. 

As well as speeding up the detection of the latest outbreaks, researchers hope the insights will enable Boehringer’s research and development efforts to be prioritised accordingly.

“External innovation is becoming an increasingly important aspect of our R&D playbook. Therefore, we are strategically partnering with Lifebit to leverage AI to monitor and interpret scientific and other sources in real-time, enabling us to track data related to animal diseases,” commented Dr Eric Haaksma, head of animal health global innovation at Boehringer Ingelheim.

“This, in turn, will accelerate the detection process as the vast amounts of scientific relevant information being produced at many levels cannot be feasibly collected and analysed manually.”

Lifebit CEO Dr Maria Chatzou-Dunford added: “At Lifebit, we thrive at connecting both, locked-up sensitive biomedical data from around the world and AI-driven automated RWE data insights – so that companies at the cutting edge of science, like Boehringer Ingelheim, can make faster and smarter decisions – delivering insights that change lives.”

Become a member or log in to add this story to your CPD history

Webinar to share tips on impactful consultations

News Story 1
 A webinar to help veterinary professionals communicate more effectively with their clients is set to be hosted by the World Small Animal Veterinary Association (WSAVA).

Taking place on Thursday 30 September, 'Top Tips for Impactful Consultations' will be led by Suzanne Rogers, co-director of Human Behaviour Change for Animals and Dr Natasha Lee, chair of the WSAVA's Animal Wellness and Welfare Committee.

For more information about the webinar, click here

Click here for more...
News Shorts
New online CPD otitis podcast created

A new 15 minute podcast on treating animals with otitis has been created by Dechra Veterinary Products. Featuring general practice vet Carolyn Kyte and veterinary dermatology specialist Natalie Barnard, the two vets will discuss their experiences treating otitis, and why owners are significant in successful treatment.

Dechra Brand Manager Carol Morgan commented: "What Carolyn and Natalie bring to the table with their new podcast for the Dechra Academy is a light and insightful discussion about communication and education being the keystone for better otitis outcomes and how vets can improve on their consultation skills to handle cases better."`

The podcast, called 'Think Differently about Otitis', is available to access for free on the Dechra Academy on-demand learning platform here.